Bymetric
UK company intelligence
Company Active LTD

Company profile

Pictura Bio Ltd

UK company 13691257, incorporated on 20 October 2021.

www.oxdx.com

Pictura Bio Ltd is a UK company with status active founded in 2021 based in Yorkshire and the Humber.

Company number
13691257
Incorporated
20 Oct 2021
Companies House status
Active

Company identity

Founded / incorporated
20 October 2021

Company number 13691257

Verify at Companies House
Legal name
PICTURA BIO LTD
Company type
LTD
Region
Yorkshire and the Humber
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 2
Pictura Bio Ltd
No active corporate controller recorded.

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
9

Company events

Reference milestones and recent Companies House filing stream events.

4 events
03 Sep
2026

Memorandum Articles

Incorporation

MA | Transaction MzU0MDc0NzI5M2FkaXF6a2N4 | Paper/PDF filed

Published 03 Sep 2026 12:50

03 Sep
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY5N1JVTjZhZGlxemtjeA | Paper/PDF filed

Published 03 Sep 2026 12:49

29 Jul
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUzNTc4MDUzNGFkaXF6a2N4

Published 29 Jul 2026 12:07

20 Oct
2021

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2023
Age at first award
0 years

Projects

2023 Collaborative R&D Lead participant

Pictura Bio: Machine learning enhanced universal point of care diagnosis platform for infectious diseases leveraging novel fluorescent labelling of enveloped pathogens - developing the Alpha Prototype.

1 Oct 2023 to 30 Jun 2025

Awarded
£672,153
Total cost £960,219

UK-based start-up PicturaBio Ltd will transform existing approaches to human virus detection, through the development of an infectious disease diagnosis platform, leveraging PicturaBio's unique pathogen identification technology, IRIS, for "facial recognition of pathogens". Infectious diseases caused by pathogens like influenza, parainfluenza, and respira...

2022 Collaborative R&D Lead participant

OxDX: Machine learning enhanced point of care diagnosis platform for infectious diseases: faster, more accessible, user intuitive, leveraging novel fluorescent labelling of enveloped viruses.

1 Sep 2022 to 31 Aug 2023

Awarded
£287,141
Total cost £410,201

UK-based start-up OxDX Ltd will transform existing approaches to human virus detection, through the development of an infectious disease diagnosis platform, leveraging OxDX's unique pathogen identification technology. Infectious diseases caused by pathogens like influenza, parainfluenza and respiratory syncytial virus cause many thousands of deaths annual...

Product types

Collaborative R&D